Zenas Biopharma, Inc. (ZBIO)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$32.88-0.12%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · ZBIO
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | |
|---|---|---|---|---|---|
| Revenues | |||||
| Revenues | — | 10.0 | 5.0 | 50.0 | — |
| Total Revenues | — | 10.0 | 5.0 | 50.0 | — |
| Operating Expenses & Income | |||||
| R&D Expenses | 213.5 | 168.1 | 139.1 | 60.0 | — |
| Operating Income | (475.6) | (383.1) | (163.9) | (37.1) | — |
| Earnings from Continuing Operations | |||||
| Interest Expense | — | 7.3 | — | — | — |
| Interest & Investment Income | — | 12.2 | — | — | — |
| Other Non-Operating Income / Expenses | (8.6) | 5.2 | 7.3 | 0.3 | — |
| EBT, Incl. Unusual Items | (484.2) | (377.8) | (156.6) | (36.8) | — |
| Income Tax Expense | — | (0.1) | 0.4 | 0.3 | — |
| Net Income | |||||
| Net Income | (484.4) | (377.7) | (157.0) | (37.1) | — |
| Per Share | |||||
| Basic EPS | (7.67) | (8.44) | (11.89) | (24.25) | — |
| Diluted EPS | (7.67) | (8.44) | (11.89) | (24.25) | — |
| Basic Weighted Avg Shares | 63.1 | 44.7 | 13.2 | 1.5 | — |
| Diluted Weighted Avg Shares | 63.1 | 44.7 | 13.2 | 1.5 | — |
| Supplemental | |||||
| EBIT | (475.6) | (383.1) | (163.9) | (37.1) | — |
| Effective Tax Rate | — | — | — | -0.8% | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.